These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Study on clinical features and factors related to long-term outcomes of antibody-negative autoimmune encephalitis. Han B; Dai Y; Peng J; Yuan T; Yin Q; Yang L Ann Clin Transl Neurol; 2024 May; 11(5):1325-1337. PubMed ID: 38644648 [TBL] [Abstract][Full Text] [Related]
4. Neurological, psychiatric, and sleep investigations after treatment of anti-leucine-rich glioma-inactivated protein 1 (LGI1) encephalitis in Spain: a prospective cohort study. Muñoz-Lopetegi A; Guasp M; Prades L; Martínez-Hernández E; Rosa-Justícia M; Patricio V; Armangué T; Rami L; Borràs R; Castro-Fornieles J; Compte A; Gaig C; Santamaria J; Dalmau J; Lancet Neurol; 2024 Mar; 23(3):256-266. PubMed ID: 38365378 [TBL] [Abstract][Full Text] [Related]
5. N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Irani SR; Bera K; Waters P; Zuliani L; Maxwell S; Zandi MS; Friese MA; Galea I; Kullmann DM; Beeson D; Lang B; Bien CG; Vincent A Brain; 2010 Jun; 133(Pt 6):1655-67. PubMed ID: 20511282 [TBL] [Abstract][Full Text] [Related]
8. Autoimmune epilepsy in children: case series and proposed guidelines for identification. Suleiman J; Brilot F; Lang B; Vincent A; Dale RC Epilepsia; 2013 Jun; 54(6):1036-45. PubMed ID: 23551014 [TBL] [Abstract][Full Text] [Related]
9. The expanding spectrum of clinically-distinctive, immunotherapy-responsive autoimmune encephalopathies. Irani SR; Vincent A Arq Neuropsiquiatr; 2012 Apr; 70(4):300-4. PubMed ID: 22510741 [TBL] [Abstract][Full Text] [Related]
10. Clinical features of 28 cases of anti Feng J; Li J; Xie Y; Lü Y; Bi F; Zhou J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):386-396. PubMed ID: 37164922 [TBL] [Abstract][Full Text] [Related]
11. Neuroimmunological antibody-mediated encephalitis and implications for diagnosis and therapy in neuropsychiatry. Marinas JE; Matveychuk D; Dursun SM; Baker GB Acta Neuropsychiatr; 2020 Aug; 32(4):177-185. PubMed ID: 31791436 [TBL] [Abstract][Full Text] [Related]
12. What is autoimmune encephalitis-associated epilepsy? Proposal of a practical definition. Rada A; Bien CG Epilepsia; 2023 Sep; 64(9):2249-2255. PubMed ID: 37353891 [TBL] [Abstract][Full Text] [Related]
13. Autoimmune encephalitis with anti-leucine-rich glioma-inactivated 1 or anti-contactin-associated protein-like 2 antibodies (formerly called voltage-gated potassium channel-complex antibodies). Bastiaansen AEM; van Sonderen A; Titulaer MJ Curr Opin Neurol; 2017 Jun; 30(3):302-309. PubMed ID: 28248701 [TBL] [Abstract][Full Text] [Related]
14. The immunobiology of autoimmune encephalitides. Alexopoulos H; Dalakas MC J Autoimmun; 2019 Nov; 104():102339. PubMed ID: 31611142 [TBL] [Abstract][Full Text] [Related]
15. [Therapy of Antibody-Associated Autoimmune Encephalitis]. Malter M; Fink GR Fortschr Neurol Psychiatr; 2016 May; 84(5):281-8. PubMed ID: 27299787 [TBL] [Abstract][Full Text] [Related]
16. [Pathophysiology and Prognostic Factors of Autoimmune Encephalitis]. Prüß H Fortschr Neurol Psychiatr; 2016 May; 84(5):264-70. PubMed ID: 27299785 [TBL] [Abstract][Full Text] [Related]
19. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Dalmau J; Gleichman AJ; Hughes EG; Rossi JE; Peng X; Lai M; Dessain SK; Rosenfeld MR; Balice-Gordon R; Lynch DR Lancet Neurol; 2008 Dec; 7(12):1091-8. PubMed ID: 18851928 [TBL] [Abstract][Full Text] [Related]